Universitätsklinikum Tübingen

Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study) (2022) Zeuschner P, Hoelters S, Stoeckle M, Seliger B, Mueller A, Bachmann HS, Gruenwald V, et al. Conference contribution A prospective, open-label, multicenter, randomized phase II trial: Sequential therapy with BEvacizumab, RAd001 (Everolimus) and AxiTinib in metastatic renal cell carcinoma (mRCC) (BERAT study of the IAG-N) (2022) Hilser T, Gruenwald V, Bergmann L, Goebell P, Strauss A, Meiler J, Hartmann A, et al. Conference contribution Interprofessional Communication about Complementary and Integrative Health (CIH): Development and Implementation of a Training Program (2022) Behzad A, Stein B, Kaltenbach A, Lohmueller L, Kroeger B, Boltenhagen U, Joos S, et al. Conference contribution The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape (2022) Doehn C, Bögemann M, Grünwald V, Welslau M, Bedke J, Schostak M, Wolf T, et al. Journal article Mindfulness and skills-based eHealth intervention to reduce distress in cancer-affected patients in the Reduct trial: Intervention protocol of the make it training optimized (2022) Heinen J, Bäuerle A, Schug C, Krakowczyk JB, Strunk SE, Wieser A, Beckord J, et al. Journal article Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma (2022) Kloker LD, Calukovic B, Benzler K, Golf A, Böhm S, Günther S, Horger M, et al. Journal article Visualization Techniques of Time-Oriented Data for the Comparison of Single Patients With Multiple Patients or Cohorts: Scoping Review (2022) Scheer J, Volkert A, Brich N, Weinert L, Santhanam N, Krone M, Ganslandt T, et al. Journal article, Review article Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria (2022) Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Ozalp SH, Lohmann L, et al. Conference contribution Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program (2022) Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, Lamprecht G, et al. Journal article, Original article